
1. j trop med hyg. 2011 sep;85(3):568-72. doi: 10.4269/ajtmh.2011.11-0194.

polymorphisms molecular markers antimalarial drug resistance and
relationship artesunate-mefloquine combination therapy patients with
uncomplicated plasmodium falciparum malaria thailand.

muhamad p(1), phompradit p, sornjai w, maensathian t, chaijaroenkul w,
rueangweerayut r, na-bangchang k.

author information: 
(1)thailand center excellence drug discovery development, thammasat
university, rangsit campus, klong luang district, pathumtani, thailand; mae-sot
general hospital, mae-sot, tak province, thailand.

the aim study investigate association genetic
polymorphisms plasmodium falciparum chloroquine resistance transporter
(pfcrt), p. falciparum multidrug resistance 1 (pfmdr1), p. falciparum atpase 
(pfatp6) clinical outcome three-day mefloquine-artesunate combination
therapy 134 patients uncomplicated plasmodium falciparum malaria an
area multidrug resistance along thailand-myanmar border. analysis of
gene mutation amplification performed nested real-time polymerase
chain reaction sybr green real-time polymerase chain reaction,
respectively. mutation pfcrt (codons 76, 220, 271, 326, 356, 371) was
found isolates (100%), whereas mutation pfmdr1 (codon 86) pfatp6
(codons 37, 693, 769, 898) found. pfmdr1 copy number significantly
higher isolates recrudescence (median number = 2.44) compared a
sensitive response (median number = 1.44). gene copy number also found to
be significantly higher paired isolates collected treatment 
time recrudescence. isolates carried one pfatp6 gene copy.

doi: 10.4269/ajtmh.2011.11-0194 
pmcid: pmc3163886
pmid: 21896824  [indexed medline]

